Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2010 Sep;83(3):700–707. doi: 10.4269/ajtmh.2010.10-0193

Quantitative Analysis of Replication and Tropisms of Dengue Virus Type 2 in Aedes albopictus

Meichun Zhang 1, Xiaoying Zheng 1, Yu Wu 1, Ming Gan 1, Ai He 1, Zhuoya Li 1, Jing Liu 1, Ximei Zhan 1,*
PMCID: PMC2929073  PMID: 20810842

Abstract

Dengue virus serotype 2 (DENV-2) RNA replication profiles and tropisms were studied by using quantitative RT-PCR (q-RTPCR) in intrathoracically infected Aedes albopictus. The virus RNA replication profiles were diverse in mosquito organs. In fat body, brain, salivary gland, and malpighian tubes, it peaked at 8, 23, 23, and 27 days post-infection, respectively, and then, all declined. In midgut, it increased all the time and had no trend of decline. In ovary, it had no apparent increase. Subsequent Western blotting of DENV-2 E protein had similar results. Using ribosomal protein 7 (rpS7) as an internal control, we found that, in salivary gland, brain, fat body, and midgut, the average DENV-2 RNA levels (DENV-2 RNA/rpS7 mRNA) were 1,028, 464, 5.6, and 6.2, respectively; in malpighian tubes, it was 1, and in ovary, it was far less than 1. These results suggest that infection profiles and tropism of DENV-2 RNA in Ae. albopictus organs are significantly different.

Introduction

Dengue virus (genus Flavivirus, family Flaviviridae) is the causative agent of dengue fever (DF) and more severe dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Dengue is now one of the world's most serious public health problems, especially in tropical and subtropical regions, with an estimated 50–100 million cases of DF, 250,000–500,000 cases of DHF, and 25,000 dengue-related deaths in the world every year. Over 2.5 billion people live in areas at risk of infection.1 The virus is comprised of four antigenically distinct serotypes [dengue virus serotype (DENV)-1 to -4]. Both Aedes aegypti and Aedes albopictus are important vectors of dengue virus in the world.2,3 Without Ae. aegypti, Ae. albopictus alone can service as a main vector to maintain dengue transmission. Over the last two decades, Ae. albopictus has spread from the western Pacific and Southeast Asia to Europe, Africa, the Middle East, North and South America, and the Caribbean.4 In some area, it replaces the native Ae. aegypti. Currently, most studies on dengue vector biology were done in Ae. aegypti. Our knowledge on how dengue interacts with Ae. albopictus is still limited.

Vector competence is the intrinsic ability of an arthropod vector to acquire, maintain, and transmit a pathogen.5 The Aedes mosquitoes become infected by DENV through an infectious blood meal (e.g., by biting a viremic individual). Dengue viruses then replicate in the midgut. The susceptibility of Aedes mosquitoes to DENV infection varies widely among different geographic strains and even among different individuals of the same strain.612 This is considered partly because of the presence of several physiological barriers in mosquitoes, including midgut infection (MIB) and escape barrier (MEB).11,1315 However, the molecular mechanism of these barriers is still unknown.

The dynamic replication of DENV in Aedes mosquitoes and different organs was already studied by immunofluorescence, immunocytochemical, and electron microscopy.1620 However, these methods cannot reflect the quantitative dynamics of virus nucleic acid in the process of infection, replication, and dissemination. Quantitative RT-PCR (q-RTPCR) as a rapid and sensitive method to quantify RNA or DNA has been used in the quantitative analysis of DENV RNA in Ae. aegypti midguts and legs.2022 But, there have no reports about the quantitative analysis of DENV replication in other mosquito organs and in Ae. albopictus organs. Aedes albopictus is the most important vector of DENV and exists extensively in mainland China, except for Hainan province, where Ae. aegypti is the most important DENV vector. Therefore, we use Ae. albopictus as a model to provide a whole picture for quantification of DENV infection in different mosquito organs.

Tropisms of dengue viruses in different mosquito organs were studied by others.1620 However, from these studies, we cannot see quantitative distribution of the virus in mosquito organs. In the absence of effective vaccine, vector control is still the only important prevention measure. Therefore, to explore the interactions between DENV and vector mosquitoes and clarify quantitative dynamics and tropism of DENV in mosquito and different organs, a more in-depth molecular mechanism of tropism will provide us useful clues to control mosquito-borne dengue transmission. In this study, we use Ae. albopictus housekeeping gene ribosomal protein 7 (rpS7) as an internal control to study the quantitative distribution of DENV-2 RNA in different mosquito organs. We also assessed virus protein expression by Western blotting to see if DENV protein expression is parallel to RNA replication in mosquito.

Materials and Methods

Ae. albopictus rearing and virus propagation.

Mosquitoes used in this study were reared at a constant temperature of 27°C and a relative humidity of 80% in an insectary under a 16-hour:8-hour (light:dark) photoperiod. Adult mosquitoes were provided with 10% glucose solution, and the females were allowed to feed on healthy Bal b/c mice to produce eggs. The New Guinea C strain of DENV-2 was propagated in C6/36 cells. Infected cells were incubated for 3–5 days in Dulbecco's modified Eagle's medium (Gibco, New York, NY) with 2% heat-inactivated fetal calf serum (ExCell, Shanghai, China) and 1% penicillin/streptomycin (Gibco). Viruses were harvested and stored as individual 1-mL aliquots in freezing tubes at −80°C. Virus titer was determined by tissue-culture infectious dose 50 (TCID50) to be 1 × 107.67/mL on C6/36 cells.

Intrathoracic inoculation of mosquitoes.

Three- to five-day-old adult female Ae. albopictus were infected by intrathoracic inoculation according to the method described by Rosen and Gubler.23 Mosquitoes were immobilized for inoculation by cold anaesthetization at −20°C for 2 minutes and inoculated with 0.2 μL virus by a glass needle. The inoculated mosquitoes were held in a separate insectary under the conditions mentioned above. At various intervals post-infection, groups of 10 mosquitoes were sampled for dissection. For the study of DENV-2 virus replication in whole mosquito body, five mosquitoes were sampled at each time point.

Mosquito dissection and RNA extraction.

Ten mosquitoes were collected and dissected in a drop of cold phosphate buffered saline (PBS) treated with diethypyrocarbonate (DEPC) at each time point. Brains, salivary glands, fat bodies, midguts, malpighian tubes, and ovaries were dissected and collected in separate 1.5-mL RNase-free microcentrifuge tubes. Before adding RNAiso Plus (TaKaRa, Otsu Shiga, Japan) for total RNA extraction, samples were washed three times with DEPC-treated PBS to remove virus contamination from haemolymph. Organs were homogenized with sterile, RNase-free pestle in RNAiso Plus, and the total RNA was extracted according to the manufacturer's instructions. The final total RNA was dissolved in 20 μL RNase-free water.

Plasmid standards construction.

DENV-2 specific primer sequences were forward (5′-TCCCTTACAAATCGCAGCAAC-3′) and reverse (5′-TGGTCTTTCCCAGCGTCAAT-3′) targeted to a 127-bp region of the DENV-2 3′ non-coding sequence. The target 127-bp fragment was amplified and cloned into pMD18-T vector (TaKaRa). The presence of target fragment in this recombinant plasmid was confirmed by direct sequencing. After quantification by ultraviolet (UV) Spectrophotometer (NanoDrop ND-1000; Thermo Fisher, Pittsburgh, PA), the recombinant plasmid was 10-fold serially diluted and stored at −20°C.

DENV-2 cDNA first-strand synthesis and q-RTPCR.

DENV-2 cDNA was synthesized using the PrimeScript RT Reagent Kit (TaKaRa) following the manufacturer's protocol. The reverse-transcription system was carried out in 10 μL reaction volume containing 1 μL total RNA, 2 μL 5× PrimeScript Buffer (for Real Time), 0.5 μL PrimeScript RT Enzyme Mix I, 0.5 μL DENV-2 specific reverse primer (10 μM), and 6 μL RNase Free dH2O. The cDNAs were stored at −20°C as the templates for q-RTPCR.

DENV-2 RNA (+) was detected by SYBR Green I-based q-RTPCR using SYBR Premix Ex Taq Kit (TaKaRa). The PCR amplification was carried out in the LightCycler480 Instrument (Roche, Basel, Switzerland). The reaction mixture contained 2 μL cDNA, 10 μL 2× SYBR Premix Ex Taq, 0.4 μL DENV-2 specific forward and reverse primer (10 μM), and 7.2 μL dH2O to a final volume of 20 μL. At the same time, a standard curve was generated by analyzing 7.72 × 101 − 7.72 × 108 copies/reaction of the DENV-2 plasmid standards mentioned above. The q-RTPCR program was 95°C for 30 seconds, followed by 40 cycles of 95°C for 5 seconds and 60°C for 20 seconds. After amplification, a melting curve was performed using the program: 95°C for 30 seconds, 65°C for 15 seconds, followed by increase to 95°C while continuously collecting the fluorescence signal.

rpS7 q-RTPCR.

Ae. albopictus rpS7 was used as internal control for q-RTPCR in this study. The primer sequences were forward (5′-ATGGTTTTCGGATCAAAGGT-3′) and reverse (5′-CGACCTTGTGTTCAATGGTG-3′).24 Plasmid standards construction, cDNA first-strand synthesis, and q-RTPCR followed the protocols described above.

DENV-2 Western blot assay.

Brains, salivary glands, fat bodies, midguts, malpighian tubes, and ovaries from 10 mosquitoes were dissected at 5, 11, 17, 23, and 32 days post-intrathoracic inoculation and washed three times with cold PBS. Total proteins were extracted by homogenizing samples in RIPA buffer (Sangon, Shanghai, China). Protein concentration was determined by BCA Protein Assay Kit (Sangon). Total proteins were boiled with 4× SDS loading buffer and separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS)-PAGE. Proteins were transferred onto nitrocellulose membranes (Pall, New York, NY) using the Mini Trans-Blot Electrophoretic Transfer Cell system (Bio-Rad, Hercules, CA). Membranes were blocked for 2 hours at room temperature with 5% nonfat milk in tris buffered saline-tween 20 (TBST) (NaCl, 0.1% Tween-20; Tris). DENV-2 was detected with a mouse monoclonal antibody raised against DENV E protein (sc-70959; Santa Cruz, CA), diluted 1/500, overnight at 4°C. Ae. albopictus actin was used as an internal control and detected with a mouse pan-actin antibody (clone C4; Millipore, Billerica, MA), diluted 1/2,000, overnight at 4°C. First antibody was detected with a 1:2,000 dilution of peroxidase-conjugated goat anti-mouse IgG (Proteintech Group, Inc., Chicago, IL) for 2 hours at room temperature. Protein bands were visualized by Super ECL Plus substrate (Andy Bio, Itasca, IL) on X-ray film (Kodak, Rochester, NY).

Results

Quantitative replication of DENV-2 RNA in Ae. albopictus.

To determine the replication profile of DENV-2 RNA (+) in whole Ae. albopictus bodies, 3- to 5-day-old adult females were infected by intrathoracic inoculation. Five mosquitoes were sampled and pooled at each time point, and dengue genome copies were measured by q-RTPCR. The replication profile of DENV-2 RNA (+) in Ae. albopictus is shown in Figure 1A. Virus RNA replication rapidly increased during the first 3 days. Then, it increased slowly and maintained at high level through the 32 days of experiment time, but they are not statistically different (P > 0.05). Virus RNA copies per mosquito at 32 days post-infection were 1.11 × 109, about 1.33 × 102 times more than the first day (P < 0.001). Subsequent Western blot analysis got the similar result that DENV-2 E glycoprotein expression was gradually increased and the largest amount of E protein was detected, even at the last time point at 32 days post-infection (Figure 1B).

Figure 1.

Figure 1.

Kinetics of DENV-2 replication in Ae. albopictus. The replications of DENV-2 (+) RNA (A) and E protein (B) in whole mosquito body were analyzed by q-RTPCR and Western blot assay (10 μg/lane), respectively, at different times post-infection. Mosquito actin (43 kDa) was used as control for protein loading. Five mosquitoes were sampled and pooled in triplicate at each time point for both q-RTPCR and Western blot assay. Statistical comparison between time of peak titer (arrow) and others was done by one-way analysis of variance (ANOVA) with Turkey's multiple comparison test. *** P < 0.001; ** P < 0.01.

Quantitative replication of DENV-2 RNA (+) in Ae. albopictus organs.

The quantitative replication of DENV-2 in mosquito midgut was already studied by using q-RTPCR.2022 In this study, besides midgut, the quantitative replications of DENV-2 in other mosquitoes organs, including brain, fat body, salivary gland, malpighian tubes, and ovary, were also determined by q-RTPCR.

The replication profiles of DENV-2 RNA (+) in Ae. albopictus organs were very different (Figure 2). The virus RNA replications were gradually increased at early time post-infection in all mosquito organs detected, but then, the difference began. In brain, fat body, salivary gland, and malpighian tubes, DENV-2 RNA (+) copies first reached a peak and then, slowly declined. The peak times in these organs were different; it was at 8 days in fat body, 23 days in brain and salivary gland, and 27 days in malpighian tubes (Figure 2C, B, A, and E). The virus RNA copies at peak time are 1.21 × 102, 1.88 × 104, 2.63 × 103, and 1.64 × 102 times more than the first day post-infection in fat body, brain, salivary gland, and malpighian tubes, respectively (P < 0.001). In midgut, DENV-2 RNA copies were increased all the time post-infection, and there was no trend of decline (Figure 2D). The virus RNA copies at last time point of 32 days post-infection in midgut were 7.03 × 102 times more than the first day (P < 0.001). In ovary, DENV-2 RNA replication was not apparent, and RNA copies at 32 days were just 12 times more than the first day and were not statistically different (P > 0.05) (Figure 2F).

Figure 2.

Figure 2.

Kinetics of DENV-2 RNA replication in Ae. albopictus organs. The replications of DENV-2 (+) RNA in different mosquito organs were analyzed by q-RTPCR at different times post-infection. Ten mosquitoes were sampled and pooled in triplicate at each time point. The results represented averages of three independent RNA copies at each time point. Statistical comparison between time of peak titer (arrow) and others was done by one-way ANOVA with Turkey's multiple comparison test. *** P < 0.001; ** P < 0.01; * P < 0.05.

DENV-2 E protein expressions in mosquito organs were detected in our study by Western blotting assay (Figure 3). The expression profiles of DENV-2 E protein were similar to virus RNA replication in mosquito organs. In brain, fat body, and salivary gland, E protein expressions were gradually increased at first, and then, all began to decline; the largest amount of E protein was detected at 23 days in brain and salivary gland and at 11 days in fat body post-infection (Figure 3A, B, and D). The E protein expression in midgut increased with time, and there was no trend of decline similar to virus RNA replication in this organ (Figure 3C). E protein expressions in malpighian tubes and ovary could not be detected; this may be caused by the low expression level of the protein in these mosquito organs (Figure 3E and F).

Figure 3.

Figure 3.

Kinetics of DENV-2 E protein expression in Ae. albopictus organs. E protein was detected by Western blot at different times post-infection. Mosquito actin (43 kDa) was used as control for protein loading. The amount of protein loaded was about 1 organ per lane. Ten mosquitoes were sampled and pooled in triplicate at each time point. (A) Brain. (B) Fat body. (C) Midgut. (D) Salivary gland. (E) Malpighian tubes. (F) Ovary.

Tropisms of DENV-2 RNA (+) in Ae. albopictus organs.

Distribution of DENV-2 antigen in mosquito organs has already been studied by immunofluorescence assays,17,18 but the quantitative distribution of DENV-2 was still unknown. In this study, we determined the quantitative distribution of DENV-2 (+) RNA in Ae. albopictus organs using q-RTPCR. The quantitative expression of housekeeping gene rpS7 mRNA was used as an internal control. The results are shown in Table 1.

Table 1.

Quantitative distribution of DENV-2 (+) RNA in Ae. albopictus organs

Mosquito organs Relative DENV-2 RNA levels (DENV-2 RNA /rpS7 mRNA)
1 day 5 day 11 day 17 day 23 day 32 day Average
Salivary gland 0.75 18.45 455.63 1,172.06 3,511.74 5,478.99 1,028.39
Brain 0.44 2.38 72.13 577.43 1354.49 1578.25 463.70
Fat body 0.05 1.08 16.23 57.54 16.38 29.21 5.60
Midgut 0.01 0.45 0.44 4.68 12.23 76.31 6.15
Malpighian tubes 0.08 0.17 0.16 0.56 1.23 4.67 0.98
Ovary 0.03 0.03 0.19 0.8 0.04 0.38 0.08

rpS7 mRNA copies in different mosquito organs were measured by q-RTPCR and used to normalized DENV-2 RNA replication levels. Relative DENV-2 RNA levels (DENV-2 RNA/rpS7 mRNA) were less than 1 in all mosquito organs detected at the first day post-infection, but difference began to emerge subsequently. The virus RNA increased rapidly in salivary gland and brain with time. Relative virus RNA levels were 18 and 2.4 at 5 days post-infection and were 5,479 and 1,578, respectively, both at 32 days post-infection. In fat body, midgut, and malpighian tubes, DENV-2 RNA replication was slow, and relative RNA levels were more than 1 at 5, 17, and 23 days post-infection, respectively; the most relative virus RNA levels were 58, 76, and 4.7 in these organs, respectively. The virus RNA replication in ovary was the least, and the relative RNA levels were less than 1 at all times. Our results indicated that salivary gland and brain were the most susceptible mosquito organs to DENV-2 infection, and the average DENV-2 RNA levels were 1,028 and 464, respectively; fat body, midgut, and malpighian tubes were less susceptible organs, and the average virus RNA levels were 5.6, 6.2, and 1.0, respectively. Ovary was not susceptible to DENV-2 infection, and the average virus RNA level was far less than 1.

Discussion

Ae. aegypti and Ae. albopictus were considered to be the main mosquito vectors of dengue virus. The growth of dengue viruses in these mosquitoes has already been studied by plaque assays and end-point titrations. However, these methods were time-consuming and laborious, and the quantification of viruses cannot be determined because of viral strains differing in their virulence to form plaque and establish infection in mosquitoes.2527 q-RTPCR as a rapid and sensitive assay has been used for quantitative analysis of the interaction between dengue virus and mosquitoes.2022,2830

The quantitative replication of DENV-2 RNA (+) in Ae. albopictus was studied by q-RTPCR in this study. The virus RNA was increased at all times post-infection through the whole 32 days of experiment time (Figure 1). The virus RNA copies were 8.32 × 106 per mosquito at first days post-infection and reached a peak titer of 1.11 × 109 copies per mosquito at the last time point 32 days post-infection. This is higher than the DENV-2 RNA titers in orally infected Ae. aegypti reported by others.22,28 Subsequently, Western blots indicated that DENV-2 protein expression was parallel to virus RNA replication and increased with time, but it had no decline. However, the results reported before indicated that DENV-2 titer peaked at an early time and then, declined in Ae. albopictus post-parenteral infection.31 The reasons were unknown. In conclusion, our results and others6,1618,27 indicated that Ae. albopictus was a very competent vector of DENV, and the relationships between DENV and Ae. albopictus deserve more attention.

q-RTPCR and Western blot results indicated that DENV-2 RNA replication and protein expression in Ae. albopictus midgut were always increased with time, and there was no decline (Figures 2D and 3C). The virus RNA titers in intrathoracically inoculated Ae. albopictus midgut in our study were less than in orally infected Ae. aegypti midgut reported by Molina-Cruz and others21 and Richardson and others.22 This is similar to the result reported by Romoser and others32 that midgut infection rates of Rift Valley fever virus in intrathoracically infected Culex pipiens were much less than in orally infected mosquitoes. Also, DENV-2 protein expression profile in midgut in this study was different from the profile in orally infected Ae. aegypti reported by Salazar and others20 and Sanchez-Vargas and others.33 In those studies, the amount of virus antigen peaked at about 10 days post-infection and then declined. Using rpS7 RNA levels as internal control, we found that the relative DENV-2 RNA levels in midgut were far less than in salivary gland and brain (Table 1). The results were consistent with the previously published results that virus particles in midgut cell cytoplasm were less than in salivary gland and brain.16 According to these results, we may speculate that there also exists a midgut reverse infection barrier (MRIB) that prevents DENV from infecting midgut epithelial cells and that DENV infection of midgut in our experiment time may represent a process of establishing infection by overcoming this infection barrier. The basal lamina around the midgut epithelium was considered to act as a virus infection barrier in arbovirus–mosquito interaction.3436 If so, the existence of MEB may also be caused by this basal lamina. However, further studies are needed to explore if MRIB exists. For example, can DENV-2 RNA or protein expression levels in midgut reach the levels in salivary gland and brain if we extend experiment time? What will happen when virus RNA levels in midgut infected through intrathoracic inoculation route are compared with those infected through blood-meal route? Certainly, immune response may also play an important role in low-level DENV-2 replication in intrathoracically inoculated mosquito midgut because of innate immune response to arbovirus infection in this organ.33,3740 Additionally, the always increased replication profiles of DENV-2 RNA and E protein in intrathoracically inoculated mosquito midgut also suggest that the progeny viruses released from orally infected midgut can reversely infect this organ; when the virus replication in orally infected midgut declines, this may be equal to another infectious blood meal. It is probably one of the reasons why the mosquito is a life-long carrier and transmitter of dengue viruses after it is infected by the virus. So far, the knowledge about the interaction between arbovirus and mosquito midgut is still very limited. Our preliminary study showed that DENV-2 infection could induce 23 differential protein expressions in midgut; most of these are down-regulated, except two up-regulated proteins (data not show). Mass-spectrometer identification of these proteins may contribute to our understanding about this arbovirus–midgut interaction.

DENV-2 RNA replication and E protein expression in fat body reached the highest level at early times post-infection (Figures 2C and 3B). It is consistent with the previously reported studies that DENV infection rates in Ae. aegypti fat body also peaked at early times post-infection.19,20,41 The virus replication in Ae. albopictus fat body was less than in brain and salivary gland in our study (Table 1). Other studies also have reported low DENV-2 replication in fat body compared with other organs.16,17 Insect fat body is the center of intermediate metabolism and powerful secretory organs responsible for the production of most immune-defense factors.42 Pathogen infections can activate a lot of immune factors expressed in mosquito fat body.4349 Therefore, immune response may play an important role in the process of DENV infection in mosquito fat body. Our results indicated that DENV-2 infection in fat body may induce rapid immune response at early times post-infection that can suppress virus replication in low level and protect fat body and even other organs from damage. However, our knowledge of the anti-viral immune response in mosquito is relatively limited at present. Fat body as a very important immune organ deserves further study.

Ae. albopictus brain was highly susceptible to DENV-2 infection, second only to salivary gland in our study (Table 1). Other studies reported previously also found high susceptibility of mosquito brain to dengue virus infection.1620,41 However, Kuberski17 found that specific fluorescence of DENV-2 in the nervous system, including brain, was more prominent than in the salivary gland. The mosquito inoculation method that we used was different from them. However, it may not be the reason for the different results between the studies; because the virus inoculated by direct intrathoracic inoculation, it was not likely to change the tropism compared with the virus released from midgut by orally infected mosquitoes. The average virus RNA level relative to rpS7 mRNA was 464, and the most relative level was 1,578 at the last time point of 32 days post-infection. This was far above the virus replication in other mosquito organs that we studied except the salivary gland. It is interesting, because there were no obvious histological changes and no impairment of cellular function in mosquito brain after DENV-2 infection.16,17 Also, DENV-2 infection did not affect the blood-feeding behavior of Ae. aegypti.41 So, there must exist some protective factors expressed by the mosquito brain itself or from haemolymph that prevent it from being damaged by dengue-virus infection.

The salivary gland is important in mosquito blood feeding, and pathogen transmission and arbovirus are transmitted to host along with saliva in the process of blood feeding. The results of q-RTPCR and Western blot indicated that the Ae. albopictus salivary gland is the most susceptible organ to DENV-2 infection that we studied (Table 1 and Figure 3). The average DENV RNA level relative to rpS7 mRNA was 1,028, and the most relative level was 5,479 at the last time point of 32 days post-infection. Western blot indicated that DENV-2 E protein expression was far more than actin in the salivary gland. Other studies also reported the similar results that the mosquito salivary glands were the most susceptible organs to DENV infection.18,41 Like DENV-2 infection in the brain, there were also no obvious histological changes and no impairment of cellular function in the salivary gland after the virus infection.16,17 Therefore, high DENV-2 replication and no pathological changes in the salivary gland may indicate that there some defense mechanisms exists to protect the organ. At present, however, little is known about the molecular process of DENV–salivary gland interaction in the mosquito. Our preliminary studies indicated that DENV-2 infection could induce 65 differentially expressed proteins in Ae. albopictus salivary glands (data not show). The identification of these proteins will help us gain a more in-depth understanding of the molecular process of DENV-2 infection in the mosquito salivary gland.

Ae. albopictus malpighian tubes could be infected by DENV-2 in our study. Studies reported previously also found that Ae. albopictus and Ae. aegypti malpighian tubes could both be infected by the virus.17,20 Although the virus RNA replication in our study was low in this organ, it indeed increased slowly with time, and the relative virus RNA level was 4.67 at 32 days post-infection (Figure 2E and Table 1). Other studies, however, have reported no virus replication of DENV-1 and -3 in mosquito malpighian tubes.18,19 It may be because different serotypes of DENV differ in their virulence of replication in mosquitoes.6,7

Many studies have shown that DENV could be transovarially transmitted to progeny mosquitoes both in the laboratory and field.5060 It was considered to be an important means for the maintenance of DENV in nature. However, the mechanism of transovarially transmission is still unclear. Studies reported before have indicated that, in the reproductive system of female mosquitoes after DENV infection, the virus could replicate in ovarioles, oviducts, accessory glands,18 or calyx19 but not in sperm thecae and ovarian follicles.1618 Using q-RTPCR, we found that DENV-2 replication in ovary was very low, and the peak virus RNA level was at 32 days post-infection, which was only 12 times more than the first day; also, the average relative DENV-2 RNA level in the ovary was far less than 1 (Figure 2F and Table 1). Our results may imply that DENV-2 can only be replicated in a special cell type or special part of mosquito reproductive system. These results may show the reasons for low rates of transovarial transmission of DENV in mosquitoes reported previously.53,56,57

The declined replication of DENV-2 in mosquito organs at late times post-infection mentioned above may be caused by the physiological function decline caused by cell aging, because our study indicated that the mRNA replication level of housekeeping gene rpS7 declined at late time points. When comparing DENV-2 replication profiles in terms of RNA copies per organs with virus RNA level relative to rpS7 mRNA, we got the different replication patterns in the same organs. It may be because the extent of DENV-2 RNA that declined in mosquito organs was less than rpS7 mRNA at late times post-infection.

In summary, according to our study, we may be able to classify mosquito organs into three classes in terms of DENV-2 tropism: salivary gland and brain are the most susceptible organs, fat body and midgut are less susceptible organs, and malpighian tubes and ovary are the least susceptible organs. However, the molecular mechanism of DENV tropism in mosquito organs is still unknown. It is considered that virus receptor on cell surface in different mosquito organs may determine DENV tropism; however, this still has not been confirmed. A lot of works need to be done for further comprehensive understanding of the interaction between mosquito and DENV. Studies for differential proteomics of Ae. albopictus organs induced by DENV-2 infection are underway in our laboratory. We hope that the identification of these differentially expressed proteins may contribute to our understanding of the molecular process of DENV infection in mosquito organs.

Acknowledgments

The authors thank Zhiyong Xi (Michigan State University) and Guoli Zhou (University of Arizona) for critically reviewing the manuscript. This work was supported by grants from the Guangzhou Medical Health and Science and Technology Major Project (2006-ZDa-004), the Guangzhou Science and Technology Project (2007Z3-E0571), and the National Natural Science Foundation of China-Guangdong Provincial People's Government of the Joint Natural Science Fund (U0632003).

Footnotes

Authors' addresses: Meichun Zhang, Xiaoying Zheng, Yu Wu, Ming Gan, Ai He, Zhuoya Li, Jing Liu and Ximei Zhan, Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China, E-mails: z02m14c588@yahoo.com.cn, zhengxy@mail.sysu.edu.cn, wuyu@mail.sysu.edu.cn, ganming75@sina.com, heai@mail.sysu.edu.cn, lizhuoya@mail.sysu.edu.cn, liujing-19840729@163.com, and zhanxm@mail.sysu.edu.cn.

References

  • 1.Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330–342. doi: 10.1016/s0188-4409(02)00378-8. [DOI] [PubMed] [Google Scholar]
  • 2.Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med. 2005;353:924–932. doi: 10.1056/NEJMra041927. [DOI] [PubMed] [Google Scholar]
  • 3.Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33–42. doi: 10.1016/s1473-3099(01)00171-2. [DOI] [PubMed] [Google Scholar]
  • 4.Gratz NG. Critical review of the vector status of Aedes albopictus. Med Vet Entomol. 2004;18:215–227. doi: 10.1111/j.0269-283X.2004.00513.x. [DOI] [PubMed] [Google Scholar]
  • 5.Woodring JL, Higgs S, Beaty BJ. In: The Biology of Disease Vectors. Beaty BJ, Marquardt WC, editors. Niwot, CO: University Press of Colorado; 1996. pp. 51–72. (Natural cycles of vector-borne pathogens). [Google Scholar]
  • 6.Gubler DJ, Rosen L. Variation among geographic strains of Aedes albopictus in susceptibility to infection with dengue viruses. Am J Trop Med Hyg. 1976;25:318–325. doi: 10.4269/ajtmh.1976.25.318. [DOI] [PubMed] [Google Scholar]
  • 7.Gubler DJ, Nalim S, Tan R, Saipan H, Sulianti Saroso J. Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am J Trop Med Hyg. 1979;28:1045–1052. doi: 10.4269/ajtmh.1979.28.1045. [DOI] [PubMed] [Google Scholar]
  • 8.Tardieux I, Poupel O, Lapchin L, Rodhain F. Variation among strains of Aedes aegypti in susceptibility to oral infection with dengue virus type 2. Am J Trop Med Hyg. 1990;43:308–313. doi: 10.4269/ajtmh.1990.43.308. [DOI] [PubMed] [Google Scholar]
  • 9.Sumanochitrapon W, Strickman D, Sithiprasasna R, Kittayapong P, Innis BL. Effect of size and geographic origin of Aedes aegypti on oral infection with dengue-2 virus. Am J Trop Med Hyg. 1998;58:283–286. doi: 10.4269/ajtmh.1998.58.283. [DOI] [PubMed] [Google Scholar]
  • 10.Vazeille-Falcoz M, Mousson L, Rodhain F, Chungue E, Failloux AB. Variation in oral susceptibility to dengue type 2 virus of populations of Aedes aegypti from the islands of Tahiti and Moorea, French Polynesia. Am J Trop Med Hyg. 1999;60:292–299. doi: 10.4269/ajtmh.1999.60.292. [DOI] [PubMed] [Google Scholar]
  • 11.Bennett KE, Olson KE, Munoz Mde L, Fernandez-Salas I, Farfan-Ale JA, Higgs S, Black WCT, Beaty BJ. Variation in vector competence for dengue 2 virus among 24 collections of Aedes aegypti from Mexico and the United States. Am J Trop Med Hyg. 2002;67:85–92. doi: 10.4269/ajtmh.2002.67.85. [DOI] [PubMed] [Google Scholar]
  • 12.Vazeille M, Rosen L, Mousson L, Failloux AB. Low oral receptivity for dengue type 2 viruses of Aedes albopictus from southeast Asia compared with that of Aedes aegypti. Am J Trop Med Hyg. 2003;68:203–208. [PubMed] [Google Scholar]
  • 13.Bosio CF, Beaty BJ, Black WCT. Quantitative genetics of vector competence for dengue-2 virus in Aedes aegypti. Am J Trop Med Hyg. 1998;59:965–970. doi: 10.4269/ajtmh.1998.59.965. [DOI] [PubMed] [Google Scholar]
  • 14.Bosio CF, Fulton RE, Salasek ML, Beaty BJ, Black WCT. Quantitative trait loci that control vector competence for dengue-2 virus in the mosquito Aedes aegypti. Genetics. 2000;156:687–698. doi: 10.1093/genetics/156.2.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sylla M, Bosio C, Urdaneta-Marquez L, Ndiaye M, Black WCT. Gene flow, subspecies composition, and dengue virus-2 susceptibility among Aedes aegypti collections in Senegal. PLoS Negl Trop Dis. 2009;3:e408. doi: 10.1371/journal.pntd.0000408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sriurairatna S, Bhamarapravati N. Replication of dengue-2 virus in Aedes albopictus mosquitoes. An electron microscopic study. Am J Trop Med Hyg. 1977;26:1199–1205. doi: 10.4269/ajtmh.1977.26.1199. [DOI] [PubMed] [Google Scholar]
  • 17.Kuberski T. Fluorescent antibody studies on the development of dengue-2 virus in Aedes albopictus (Diptera: Culicidae) J Med Entomol. 1979;16:343–349. doi: 10.1093/jmedent/16.4.343. [DOI] [PubMed] [Google Scholar]
  • 18.Chen WJ, Wei HL, Hsu EL, Chen ER. Vector competence of Aedes albopictus and Ae. aegypti (Diptera: Culicidae) to dengue 1 virus on Taiwan: development of the virus in orally and parenterally infected mosquitoes. J Med Entomol. 1993;30:524–530. doi: 10.1093/jmedent/30.3.524. [DOI] [PubMed] [Google Scholar]
  • 19.Linthicum KJ, Platt K, Myint KS, Lerdthusnee K, Innis BL, Vaughn DW. Dengue 3 virus distribution in the mosquito Aedes aegypti: an immunocytochemical study. Med Vet Entomol. 1996;10:87–92. doi: 10.1111/j.1365-2915.1996.tb00086.x. [DOI] [PubMed] [Google Scholar]
  • 20.Salazar MI, Richardson JH, Sanchez-Vargas I, Olson KE, Beaty BJ. Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes. BMC Microbiol. 2007;7:9. doi: 10.1186/1471-2180-7-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Molina-Cruz A, Gupta L, Richardson J, Bennett K, Black WT, Barillas-Mury C. Effect of mosquito midgut trypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti. Am J Trop Med Hyg. 2005;72:631–637. [PubMed] [Google Scholar]
  • 22.Richardson J, Molina-Cruz A, Salazar MI, Black WT. Quantitative analysis of dengue-2 virus RNA during the extrinsic incubation period in individual Aedes aegypti. Am J Trop Med Hyg. 2006;74:132–141. [PubMed] [Google Scholar]
  • 23.Rosen L, Gubler D. The use of mosquitoes to detect and propagate dengue viruses. Am J Trop Med Hyg. 1974;23:1153–1160. doi: 10.4269/ajtmh.1974.23.1153. [DOI] [PubMed] [Google Scholar]
  • 24.Wu Y, Parthasarathy R, Bai H, Palli SR. Mechanisms of midgut remodeling: juvenile hormone analog methoprene blocks midgut metamorphosis by modulating ecdysone action. Mech Dev. 2006;123:530–547. doi: 10.1016/j.mod.2006.05.005. [DOI] [PubMed] [Google Scholar]
  • 25.Gubler DJ, Novak RJ, Vergne E, Colon NA, Velez M, Fowler J. Aedes (Gymnometopa) mediovittatus (Diptera: Culicidae), a potential maintenance vector of dengue viruses in Puerto Rico. J Med Entomol. 1985;22:469–475. doi: 10.1093/jmedent/22.5.469. [DOI] [PubMed] [Google Scholar]
  • 26.Watts DM, Burke DS, Harrison BA, Whitmire RE, Nisalak A. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg. 1987;36:143–152. doi: 10.4269/ajtmh.1987.36.143. [DOI] [PubMed] [Google Scholar]
  • 27.Johnson BW, Chambers TV, Crabtree MB, Bhatt TR, Guirakhoo F, Monath TP, Miller BR. Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes. Am J Trop Med Hyg. 2002;67:260–265. doi: 10.4269/ajtmh.2002.67.260. [DOI] [PubMed] [Google Scholar]
  • 28.Armstrong PM, Rico-Hesse R. Differential susceptibility of Aedes aegypti to infection by the American and southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis. 2001;1:159–168. doi: 10.1089/153036601316977769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Armstrong PM, Rico-Hesse R. Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg. 2003;68:539–544. doi: 10.4269/ajtmh.2003.68.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Johnson BW, Chambers TV, Crabtree MB, Guirakhoo F, Monath TP, Miller BR. Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. Am J Trop Med Hyg. 2004;70:89–97. [PubMed] [Google Scholar]
  • 31.Gubler DJ, Rosen L. Quantitative aspects of replication of dengue viruses in Aedes albopictus (Diptera: Culicidae) after oral and parenteral infection. J Med Entomol. 1977;31:469–472. doi: 10.1093/jmedent/13.4-5.469. [DOI] [PubMed] [Google Scholar]
  • 32.Romoser WS, Faran ME, Bailey CL, Lerdthusnee K. An immunocytochemical study of the distribution of Rift Valley fever virus in the mosquito Culex pipiens. Am J Trop Med Hyg. 1992;46:489–501. doi: 10.4269/ajtmh.1992.46.489. [DOI] [PubMed] [Google Scholar]
  • 33.Sanchez-Vargas I, Scott JC, Poole-Smith BK, Franz AW, Barbosa-Solomieu V, Wilusz J, Olson KE, Blair CD. Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathog. 2009;5:e1000299. doi: 10.1371/journal.ppat.1000299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Weaver SC, Scott TW, Lorenz LH, Lerdthusnee K, Romoser WS. Togavirus-associated pathologic changes in the midgut of a natural mosquito vector. J Virol. 1988;62:2083–2090. doi: 10.1128/jvi.62.6.2083-2090.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Romoser WS, Wasieloski LP, Jr, Pushko P, Kondig JP, Lerdthusnee K, Neira M, Ludwig GV. Evidence for arbovirus dissemination conduits from the mosquito (Diptera: Culicidae) midgut. J Med Entomol. 2004;41:467–475. doi: 10.1603/0022-2585-41.3.467. [DOI] [PubMed] [Google Scholar]
  • 36.Romoser WS, Turell MJ, Lerdthusnee K, Neira M, Dohm D, Ludwig G, Wasieloski L. Pathogenesis of Rift Valley fever virus in mosquitoes—tracheal conduits and the basal lamina as an extra-cellular barrier. Arch Virol Suppl. 2005;19:89–100. doi: 10.1007/3-211-29981-5_8. [DOI] [PubMed] [Google Scholar]
  • 37.Sanders HR, Foy BD, Evans AM, Ross LS, Beaty BJ, Olson KE, Gill SS. Sindbis virus induces transport processes and alters expression of innate immunity pathway genes in the midgut of the disease vector, Aedes aegypti. Insect Biochem Mol Biol. 2005;35:1293–1307. doi: 10.1016/j.ibmb.2005.07.006. [DOI] [PubMed] [Google Scholar]
  • 38.Bryant B, Blair CD, Olson KE, Clem RJ. Annotation and expression profiling of apoptosis-related genes in the yellow fever mosquito, Aedes aegypti. Insect Biochem Mol Biol. 2008;38:331–345. doi: 10.1016/j.ibmb.2007.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Campbell CL, Keene KM, Brackney DE, Olson KE, Blair CD, Wilusz J, Foy BD. Aedes aegypti uses RNA interference in defense against Sindbis virus infection. BMC Microbiol. 2008;8:47. doi: 10.1186/1471-2180-8-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Xi Z, Ramirez JL, Dimopoulos G. The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathog. 2008;4:e1000098. doi: 10.1371/journal.ppat.1000098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Platt KB, Linthicum KJ, Myint KS, Innis BL, Lerdthusnee K, Vaughn DW. Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg. 1997;57:119–125. doi: 10.4269/ajtmh.1997.57.119. [DOI] [PubMed] [Google Scholar]
  • 42.Raikhel AS, Deitsch KW, Sappington TW. In: Molecular Biology of Insect Disease Vectors. Crampton JM, Beard CB, Louis C, editors. London: Chapman Hall; 1997. pp. 507–522. (Culture and analysis of the insect fat body). [Google Scholar]
  • 43.Dimopoulos G, Richman A, Muller HM, Kafatos FC. Molecular immune responses of the mosquito Anopheles gambiae to bacteria and malaria parasites. Proc Natl Acad Sci USA. 1997;94:11508–11513. doi: 10.1073/pnas.94.21.11508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gorman MJ, Andreeva OV, Paskewitz SM. Sp22D: a multidomain serine protease with a putative role in insect immunity. Gene. 2000;251:9–17. doi: 10.1016/s0378-1119(00)00181-5. [DOI] [PubMed] [Google Scholar]
  • 45.Dimopoulos G, Muller HM, Levashina EA, Kafatos FC. Innate immune defense against malaria infection in the mosquito. Curr Opin Immunol. 2001;13:79–88. doi: 10.1016/s0952-7915(00)00186-2. [DOI] [PubMed] [Google Scholar]
  • 46.Shi L, Paskewitz SM. Identification and molecular characterization of two immune-responsive chitinase-like proteins from Anopheles gambiae. Insect Mol Biol. 2004;13:387–398. doi: 10.1111/j.0962-1075.2004.00496.x. [DOI] [PubMed] [Google Scholar]
  • 47.Shin SW, Kokoza V, Bian G, Cheon HM, Kim YJ, Raikhel AS. REL1, a homologue of Drosophila dorsal, regulates toll antifungal immune pathway in the female mosquito Aedes aegypti. J Biol Chem. 2005;280:16499–16507. doi: 10.1074/jbc.M500711200. [DOI] [PubMed] [Google Scholar]
  • 48.Cheon HM, Shin SW, Bian G, Park JH, Raikhel AS. Regulation of lipid metabolism genes, lipid carrier protein lipophorin, and its receptor during immune challenge in the mosquito Aedes aegypti. J Biol Chem. 2006;281:8426–8435. doi: 10.1074/jbc.M510957200. [DOI] [PubMed] [Google Scholar]
  • 49.Cooper DM, Chamberlain CM, Lowenberger C. Aedes FADD: a novel death domain-containing protein required for antibacterial immunity in the yellow fever mosquito, Aedes aegypti. Insect Biochem Mol Biol. 2009;39:47–54. doi: 10.1016/j.ibmb.2008.09.011. [DOI] [PubMed] [Google Scholar]
  • 50.Khin MM, Than KA. Transovarial transmission of dengue 2 virus by Aedes aegypti in nature. Am J Trop Med Hyg. 1983;32:590–594. doi: 10.4269/ajtmh.1983.32.590. [DOI] [PubMed] [Google Scholar]
  • 51.Rosen L, Shroyer DA, Tesh RB, Freier JE, Lien JC. Transovarial transmission of dengue viruses by mosquitoes: Aedes albopictus and Aedes aegypti. Am J Trop Med Hyg. 1983;32:1108–1119. doi: 10.4269/ajtmh.1983.32.1108. [DOI] [PubMed] [Google Scholar]
  • 52.Hull B, Tikasingh E, de Souza M, Martinez R. Natural transovarial transmission of dengue 4 virus in Aedes aegypti in Trinidad. Am J Trop Med Hyg. 1984;33:1248–1250. doi: 10.4269/ajtmh.1984.33.1248. [DOI] [PubMed] [Google Scholar]
  • 53.Freier JE, Rosen L. Vertical transmission of dengue viruses by mosquitoes of the Aedes scutellaris group. Am J Trop Med Hyg. 1987;37:640–647. doi: 10.4269/ajtmh.1987.37.640. [DOI] [PubMed] [Google Scholar]
  • 54.Freier JE, Rosen L. Vertical transmission of dengue viruses by Aedes mediovittatus. Am J Trop Med Hyg. 1988;39:218–222. doi: 10.4269/ajtmh.1988.39.218. [DOI] [PubMed] [Google Scholar]
  • 55.Mitchell CJ, Miller BR. Vertical transmission of dengue viruses by strains of Aedes albopictus recently introduced into Brazil. J Am Mosq Control Assoc. 1990;6:251–253. [PubMed] [Google Scholar]
  • 56.Shroyer DA. Vertical maintenance of dengue-1 virus in sequential generations of Aedes albopictus. J Am Mosq Control Assoc. 1990;6:312–314. [PubMed] [Google Scholar]
  • 57.Bosio CF, Thomas RE, Grimstad PR, Rai KS. Variation in the efficiency of vertical transmission of dengue-1 virus by strains of Aedes albopictus (Diptera: Culicidae) J Med Entomol. 1992;29:985–989. doi: 10.1093/jmedent/29.6.985. [DOI] [PubMed] [Google Scholar]
  • 58.Mourya DT, Gokhale MD, Basu A, Barde PV, Sapkal GN, Padbidri VS, Gore MM. Horizontal and vertical transmission of dengue virus type 2 in highly and lowly susceptible strains of Aedes aegypti mosquitoes. Acta Virol. 2001;45:67–71. [PubMed] [Google Scholar]
  • 59.Joshi V, Mourya DT, Sharma RC. Persistence of dengue-3 virus through transovarial transmission passage in successive generations of Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2002;67:158–161. doi: 10.4269/ajtmh.2002.67.158. [DOI] [PubMed] [Google Scholar]
  • 60.Thenmozhi V, Hiriyan JG, Tewari SC, Philip Samuel P, Paramasivan R, Rajendran R, Mani TR, Tyagi BK. Natural vertical transmission of dengue virus in Aedes albopictus (Diptera: Culicidae) in Kerala, a southern Indian state. Jpn J Infect Dis. 2007;60:245–249. [PubMed] [Google Scholar]

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES